Cargando…
Changes in pulmonary endothelial cell properties during bleomycin-induced pulmonary fibrosis
BACKGROUND: Pulmonary fibrosis is a progressive and lethal disease characterized by damage to the lung parenchyma with excess extracellular matrix deposition. The involvement of endothelial cells in fibrosis development is unclear. METHODS: We isolated pulmonary endothelial cells, using a magnetic-a...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6019800/ https://www.ncbi.nlm.nih.gov/pubmed/29940932 http://dx.doi.org/10.1186/s12931-018-0831-y |
_version_ | 1783335185472815104 |
---|---|
author | Kato, Shinpei Inui, Naoki Hakamata, Akio Suzuki, Yuzo Enomoto, Noriyuki Fujisawa, Tomoyuki Nakamura, Yutaro Watanabe, Hiroshi Suda, Takafumi |
author_facet | Kato, Shinpei Inui, Naoki Hakamata, Akio Suzuki, Yuzo Enomoto, Noriyuki Fujisawa, Tomoyuki Nakamura, Yutaro Watanabe, Hiroshi Suda, Takafumi |
author_sort | Kato, Shinpei |
collection | PubMed |
description | BACKGROUND: Pulmonary fibrosis is a progressive and lethal disease characterized by damage to the lung parenchyma with excess extracellular matrix deposition. The involvement of endothelial cells in fibrosis development is unclear. METHODS: We isolated pulmonary endothelial cells, using a magnetic-activated cell sorting system, from mice with pulmonary fibrosis induced by intratracheal bleomycin. We characterized endothelial cells isolated at various times in the course of pulmonary fibrosis development. RESULTS: Inflammatory cell infiltration was observed at 7 days after bleomycin administration, and fibrotic changes with increased collagen content were observed on day 21. Endothelial cells were isolated at these two timepoints. Levels of von Willebrand factor, plasminogen activator inhibitor-1 and matrix metalloproteinase-12 were elevated in lung endothelial cells isolated from bleomycin-treated mice at days 7 and 21. This indicated that intratracheal bleomycin administration induced endothelium injury. Expression of fibrogenic mediators, transforming growth factor (TGF)-β, connective tissue growth factor and platelet-derived growth factor-C was elevated in the cells from bleomycin-treated, compared with untreated, lungs. When endothelial cells were treated with TGF-β, α-smooth muscle actin (SMA) expression and collagen production were increased only in those cells from bleomycin-treated mouse lungs. Thapsigargin-induced prostaglandin I(2) and nitric oxide production, decreased in endothelial cells from bleomycin-treated mouse lungs, compared with controls, was further suppressed by TGF-β. CONCLUSION: Bleomycin administration induced functional changes in lung endothelial cells, indicating potential involvement of endothelium in pulmonary fibrogenesis. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12931-018-0831-y) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-6019800 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-60198002018-07-06 Changes in pulmonary endothelial cell properties during bleomycin-induced pulmonary fibrosis Kato, Shinpei Inui, Naoki Hakamata, Akio Suzuki, Yuzo Enomoto, Noriyuki Fujisawa, Tomoyuki Nakamura, Yutaro Watanabe, Hiroshi Suda, Takafumi Respir Res Research BACKGROUND: Pulmonary fibrosis is a progressive and lethal disease characterized by damage to the lung parenchyma with excess extracellular matrix deposition. The involvement of endothelial cells in fibrosis development is unclear. METHODS: We isolated pulmonary endothelial cells, using a magnetic-activated cell sorting system, from mice with pulmonary fibrosis induced by intratracheal bleomycin. We characterized endothelial cells isolated at various times in the course of pulmonary fibrosis development. RESULTS: Inflammatory cell infiltration was observed at 7 days after bleomycin administration, and fibrotic changes with increased collagen content were observed on day 21. Endothelial cells were isolated at these two timepoints. Levels of von Willebrand factor, plasminogen activator inhibitor-1 and matrix metalloproteinase-12 were elevated in lung endothelial cells isolated from bleomycin-treated mice at days 7 and 21. This indicated that intratracheal bleomycin administration induced endothelium injury. Expression of fibrogenic mediators, transforming growth factor (TGF)-β, connective tissue growth factor and platelet-derived growth factor-C was elevated in the cells from bleomycin-treated, compared with untreated, lungs. When endothelial cells were treated with TGF-β, α-smooth muscle actin (SMA) expression and collagen production were increased only in those cells from bleomycin-treated mouse lungs. Thapsigargin-induced prostaglandin I(2) and nitric oxide production, decreased in endothelial cells from bleomycin-treated mouse lungs, compared with controls, was further suppressed by TGF-β. CONCLUSION: Bleomycin administration induced functional changes in lung endothelial cells, indicating potential involvement of endothelium in pulmonary fibrogenesis. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12931-018-0831-y) contains supplementary material, which is available to authorized users. BioMed Central 2018-06-26 2018 /pmc/articles/PMC6019800/ /pubmed/29940932 http://dx.doi.org/10.1186/s12931-018-0831-y Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Kato, Shinpei Inui, Naoki Hakamata, Akio Suzuki, Yuzo Enomoto, Noriyuki Fujisawa, Tomoyuki Nakamura, Yutaro Watanabe, Hiroshi Suda, Takafumi Changes in pulmonary endothelial cell properties during bleomycin-induced pulmonary fibrosis |
title | Changes in pulmonary endothelial cell properties during bleomycin-induced pulmonary fibrosis |
title_full | Changes in pulmonary endothelial cell properties during bleomycin-induced pulmonary fibrosis |
title_fullStr | Changes in pulmonary endothelial cell properties during bleomycin-induced pulmonary fibrosis |
title_full_unstemmed | Changes in pulmonary endothelial cell properties during bleomycin-induced pulmonary fibrosis |
title_short | Changes in pulmonary endothelial cell properties during bleomycin-induced pulmonary fibrosis |
title_sort | changes in pulmonary endothelial cell properties during bleomycin-induced pulmonary fibrosis |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6019800/ https://www.ncbi.nlm.nih.gov/pubmed/29940932 http://dx.doi.org/10.1186/s12931-018-0831-y |
work_keys_str_mv | AT katoshinpei changesinpulmonaryendothelialcellpropertiesduringbleomycininducedpulmonaryfibrosis AT inuinaoki changesinpulmonaryendothelialcellpropertiesduringbleomycininducedpulmonaryfibrosis AT hakamataakio changesinpulmonaryendothelialcellpropertiesduringbleomycininducedpulmonaryfibrosis AT suzukiyuzo changesinpulmonaryendothelialcellpropertiesduringbleomycininducedpulmonaryfibrosis AT enomotonoriyuki changesinpulmonaryendothelialcellpropertiesduringbleomycininducedpulmonaryfibrosis AT fujisawatomoyuki changesinpulmonaryendothelialcellpropertiesduringbleomycininducedpulmonaryfibrosis AT nakamurayutaro changesinpulmonaryendothelialcellpropertiesduringbleomycininducedpulmonaryfibrosis AT watanabehiroshi changesinpulmonaryendothelialcellpropertiesduringbleomycininducedpulmonaryfibrosis AT sudatakafumi changesinpulmonaryendothelialcellpropertiesduringbleomycininducedpulmonaryfibrosis |